Characteristics of malignancies in the LERIC cohort
| Type | No. of tumours | Mean age at diagnosis of malignancy, y (range) | Interval between first transplantation and diagnosis, y (range)2-150 | Mean follow up time after diagnosis, y (range) | No. of patients who died due to malignancy |
| Skin cancer | 13 | 27.8 (14.3–34.5) | 15.0 (5.5–20.2) | 3.6 (0.4–12.9) | 0 |
| SCC | 7 | 0 | |||
| BCC | 3 | 0 | |||
| Melanoma | 2 | 0 | |||
| M. Bowen | 1 | 0 | |||
| Non-Hodgkin lymphoma | 5 | 23.5 (11.1–31.1) | 11.7 (0.6–19.9) | 0.6 (0.0–1.7) | 4 |
| ALL | 1 | 1 | |||
| Fibrosarcoma | 1 | 1 | |||
| Grawitz tumour | 1 | 0 | |||
| Leiomyosarcoma | 1 | 0 | |||
| Total | 22 | 25.9 (11.1–34.5) | 12.9 (0.1–21.1) | 2.6 (0.0–12.9) | 6 |
↵2-150 Excluding one patient with malignant melanoma who never underwent transplantation.
SCC, squamous cell carcinoma; BCC, basal cell carcinoma; ALL, acute lymphatic leukaemia.